Reply to Stephen B. Williams and Ashish M. Kamat's Letter to the Editor re: Samantha Cambier, Richard J. Sylvester, Laurence Collette, et al. EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guérin. Eur Urol 2016;69:60-9

Richard Sylvester; Paolo Gontero; Jorg Oddens

doi:10.1016/j.eururo.2016.01.055

Reply to Stephen B. Williams and Ashish M. Kamat's Letter to the Editor re: Samantha Cambier, Richard J. Sylvester, Laurence Collette, et al. EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guérin. Eur Urol 2016;69:60-9

Richard Sylvester^*
, Paolo Gontero
, Jorg Oddens

^*Corresponding author for this work

EAU Guidelines Office
University of Turin

Research output: Contribution to journal › Comment/Letter to the editor › Academic

Original language	English
Pages (from-to)	e123-e124
Journal	European urology
Volume	69
Issue number	6
DOIs	https://doi.org/10.1016/j.eururo.2016.01.055
Publication status	Published - 1 Jun 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.eururo.2016.01.055

Cite this

Sylvester, R., Gontero, P., & Oddens, J. (2016). Reply to Stephen B. Williams and Ashish M. Kamat's Letter to the Editor re: Samantha Cambier, Richard J. Sylvester, Laurence Collette, et al. EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guérin. Eur Urol 2016;69:60-9. European urology, 69(6), e123-e124. https://doi.org/10.1016/j.eururo.2016.01.055

Sylvester, Richard ; Gontero, Paolo ; Oddens, Jorg. / Reply to Stephen B. Williams and Ashish M. Kamat's Letter to the Editor re : Samantha Cambier, Richard J. Sylvester, Laurence Collette, et al. EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guérin. Eur Urol 2016;69:60-9. In: European urology. 2016 ; Vol. 69, No. 6. pp. e123-e124.

@article{80351688602a486891a692ef12b0fbf5,

title = "Reply to Stephen B. Williams and Ashish M. Kamat's Letter to the Editor re: Samantha Cambier, Richard J. Sylvester, Laurence Collette, et al. EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Gu{\'e}rin. Eur Urol 2016;69:60-9",

author = "Richard Sylvester and Paolo Gontero and Jorg Oddens",

year = "2016",

month = jun,

day = "1",

doi = "10.1016/j.eururo.2016.01.055",

language = "English",

volume = "69",

pages = "e123--e124",

journal = "European urology",

issn = "0302-2838",

publisher = "Elsevier",

number = "6",

}

Sylvester, R, Gontero, P & Oddens, J 2016, 'Reply to Stephen B. Williams and Ashish M. Kamat's Letter to the Editor re: Samantha Cambier, Richard J. Sylvester, Laurence Collette, et al. EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guérin. Eur Urol 2016;69:60-9', European urology, vol. 69, no. 6, pp. e123-e124. https://doi.org/10.1016/j.eururo.2016.01.055

Reply to Stephen B. Williams and Ashish M. Kamat's Letter to the Editor re: Samantha Cambier, Richard J. Sylvester, Laurence Collette, et al. EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guérin. Eur Urol 2016;69:60-9. / Sylvester, Richard; Gontero, Paolo; Oddens, Jorg.
In: European urology, Vol. 69, No. 6, 01.06.2016, p. e123-e124.

Research output: Contribution to journal › Comment/Letter to the editor › Academic

TY - JOUR

T1 - Reply to Stephen B. Williams and Ashish M. Kamat's Letter to the Editor re

T2 - Samantha Cambier, Richard J. Sylvester, Laurence Collette, et al. EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guérin. Eur Urol 2016;69:60-9

AU - Sylvester, Richard

AU - Gontero, Paolo

AU - Oddens, Jorg

PY - 2016/6/1

Y1 - 2016/6/1

UR - https://www.scopus.com/pages/publications/84957922714

U2 - 10.1016/j.eururo.2016.01.055

DO - 10.1016/j.eururo.2016.01.055

M3 - Comment/Letter to the editor

C2 - 26874805

SN - 0302-2838

VL - 69

SP - e123-e124

JO - European urology

JF - European urology

IS - 6

ER -

Sylvester R, Gontero P, Oddens J. Reply to Stephen B. Williams and Ashish M. Kamat's Letter to the Editor re: Samantha Cambier, Richard J. Sylvester, Laurence Collette, et al. EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guérin. Eur Urol 2016;69:60-9. European urology. 2016 Jun 1;69(6):e123-e124. doi: 10.1016/j.eururo.2016.01.055

UN SDGs

Access to Document

Other files and links

Cite this